Global cell line development services market demand is anticipated to be valued at USD 6,365.2 million in 2023. The overall market is forecasted to grow at a CAGR of 7.4% over the years from 2023 to 2033. In addition to this, FMI predicts the global market is to be valued at USD 12,957.8 million by end of year 2033.
The growth of the market can be attributed to continuous research and technological advancement in the biotechnology sector. From 2018 to 2022 a CAGR of 6.5% was registered for the market.
Cell is the basic unit of life, cell lines are the culture developed from a single cell, and the cell line is developed in the lab under natural conditions where the cell can grow and proliferate indefinitely. The cell line growth needs various nutrients and growth factors.
The stem cell is generally picked for culture. The cell line is categorized in three segments according to the sources: normally taken from tumor tissue, transformed into normal cells undergoes change under genetic to be tumor cells and stem cells therapy which is can generate different cell types and based on morphology the cell is segmented into three types, as epithelial, lymphoblast and fibroblast.
| Report Attributes or Data Points | Details |
|---|---|
| Global Cell Line Development Services Market Valuation in 2022 | USD 5,966 million |
| Estimated Global Market Share in 2023 | USD 6,365.2 million |
| Forecasted Global Market Size by 2033 | USD 12,957.8 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 7.4% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 6.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Innovations and technological advancements in biotechnology are steering the growth in the this services market
Cell line development services are increasing over the forecast period as the application area is increasing and the participation of research institutes have also increased to explore the application, such as cancer, and cell development.
The number of patients suffering from cancer will affect the market growth and also the support provided by the government agency to increase biotechnological research activities. For instance, in April 2017, Solentim launched VIPS (Validated In-situ Plate Seeding) a new single cell dispensing system for cell line development.
Cell line development services are a growing market over the forecast period, as the players and research institutes have developed more advanced technology and applications. Cell line technology is vastly used in various research and biotechnology industries.
Increased vaccine production will drive the overall market. Increasing R&D expenditure to produce antibiotics, vaccines and other biological substances will accelerate the market growth.
Lack of awareness about the application of the product may restrain the growth of the market
The factor which affects the market of this segment is the increased demand for monoclonal antibodies and the high demand for vaccines for both humans and animals. High cost and the lack of awareness about the product along with its application are acting as a hindrance to the market.
In addition, cell line contamination too is derailing the progress of the market. The absence of a favorable and adequate reimbursement scenario in developing and underdeveloped economies will also dampen market growth rates.
| Category | By Product Type |
|---|---|
| Top Segment | Reagent and Media |
| Market Share in Percentage | 54.34% |
| Category | By Cell Lines |
|---|---|
| Top Segment | Recombinant Cell Lines |
| Market Share in Percentage | 32.58% |
Principal Consultant
Development of Biotechnology in North America Accounts for Growth of the Market in the Region
Two important factors are influencing the growth of the market. The increasing cases of cancer in the United States is largely contributing to the growth of the market. In addition, the development of the biotechnology sector is playing a key role in the escalating growth of the market.
Furthermore, the integration of technology is up scaling the process of cell line development services. Thus, due to the aforementioned regions, North America held 31.4% market share of the market in 2022.
For instance, in December 2021 - Merck, announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the first vaccine production facility in Nigeria.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 31.4% |
| Europe | 25.3% |
Technological Advancement to Boost the Growth of Cell Line Development Services Market in Europe
The growing prominence of the biotechnology sector along with government initiatives is propelling the development of cell line development services in the European region. Furthermore, as Europe is a hotspot for technological advancements, the biotechnology sector is rapidly developing.
This, in turn, is escalating the growth of cell line development services. Thus, owing to the reasons mentioned above, Europe possessed a 25.3% market share in 2022. The growth of the market in Europe is attributed to increased R&D expenditure due to technological developments. These advances are followed by new drug discoveries triggering the adoption of different but unique procedures for bio production.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 28.6% |
| Germany | 5.3% |
| Japan | 6.3% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Rise in the Demand for Biotherapeutics in the Region Is a Major Factor Driving the Global Cell Line Development Services Market
Asia Pacific market is expected to grow significantly during the forecast years. High availability of the cell line development services for bio production, increasing introduction of new antibiotics, and vaccine production will drive sales of cell line development services in biopharmaceutical companies.
The growth of the region can be attributed to increasing government funding and private initiatives for research and development programs for automated cell line development in countries like China, and India. Additionally, increasing demand for biopharmaceuticals and regenerative medicines is expected to boost the growth of the market in the region.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 6.6% |
| China | 7.2% |
| India | 8% |
| Australia | 6.2% |
Some of the key start-up players in the cell line development market are Ribbon BioLabs, Centarix Biotech, CytoRecovery, MicroByre, Leonyte Biosystems, spherefluidics, AcceGen, Bhat bio-tech India private limited, Imgenex India.
Some of the key participants present in the global cell line development services market include Lonza, MabPlex Inc., Thermo Fisher Scientific, Inc., Solentim Ltd, Sigma-Aldrich Corporation, Selexis, Corning, Inc, Wuxi App Tec, Inc. and Sartorius AG among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Lonza, MabPlex Inc., Thermo Fisher Scientific, Inc., and Solentim Ltd account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.4% from 2023 to 2033 |
| Estimated Market Value (2022) | USD 5,966 million |
| Anticipated Forecast Value (2033) | USD 12,957.8 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million, Volume in Kilotons and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Type, Application, Region |
| Regions Covered | North America; Latin America; Europe; Asia pacific; Middle East and Africa |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, United Kingdom, Italy, Nordics, BENELUX, Australia & New Zealand, China, Japan, South Korea, GCC, South Africa, Turkey |
| Key Companies Profiled | Lonza; MabPlex Inc.; Thermo Fisher Scientific, Inc.; Solentim Ltd; Sigma-Aldrich Corporation; Selexis; Corning, Inc; Wuxi App Tec Inc.; Sartorius AG |
| Customization | Available Upon Request |
The market is valued at USD 6,365.2 million in 2023.
From 2018 to 2022, the market registered a CAGR of 6.5%.
The market shall reach USD 12,957.8 million in 2033.
The market’s CAGR from 2023 to 2033 will be 7.4%.
North America held 31.4% market share of the market in 2022
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Media and Reagents 5.2. Equipment 5.3. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Primary 6.2. Continuous 6.3. Hybridomas 6.4. Recombinant 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Bioproduction 7.2. Diagnostics 7.3. Vaccines 7.4. Recombinant Protein Therapeutics 7.5. Tissue Engineering & Regenerative Medicines 7.6. Drug Discovery 7.7. Toxicity Testing 7.8. Pharmaceutical and Biotechnology Research 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Lonza 18.2. MabPlex Inc. 18.3. Thermo Fisher Scientific, Inc. 18.4. Solentim Ltd 18.5. Sigma-Aldrich Corporation 18.6. Selexis 18.7. Corning, Inc 18.8. Wuxi App Tec Inc. 18.9. Sartorius AG 18.10. AGC Inc 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Cell Line Development Services Market
